Skip to main content
Log in

Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Treatment for oropharyngeal cancer (OPC) has changed over the past two decades under multiple influences. We provide a population-based description of the application of radiotherapy, surgery, and chemotherapy to OPC in 1997, 2004, and 2009.

Methods

The National Cancer Institute’s Patterns of Care study for OPC included multiple variables not available in the public-use dataset. We identified factors correlating with selection of primary surgery versus radiotherapy with or without chemotherapy (RTC) and analyzed predictors of all-cause mortality. We estimated the frequency of human papillomavirus (HPV) testing.

Results

RTC was more common in 2009 than in 1997, and was more commonly applied to Stage IV cases. However, RTC was not an independent risk factor for mortality compared with surgery. HPV status was known in 14% of patients in 2009.

Conclusions

RTC is the most common treatment for OPC, but it may not provide the best outcomes. HPV testing was uncommon in 2009.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001) Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res Health 25:263–270

    CAS  PubMed  Google Scholar 

  2. Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biorklund A, Rutqvist LE (1998) Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82:1367–1375

    Article  CAS  PubMed  Google Scholar 

  3. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294–4301

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 113:2901–2909

    Article  PubMed  Google Scholar 

  5. Weber RS, Gidley P, Morrison WH, Peters LJ, Hankins P, Wolf P, Guillamondegui O (1990) Treatment selection for carcinoma of the base of the tongue. Am J Surg 160:415–419

    Article  CAS  PubMed  Google Scholar 

  6. Allal AS, Nicoucar K, Mach N, Dulguerov P (2003) Quality of life in patients with oropharynx carcinomas: Assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck 25:833–839

    Article  Google Scholar 

  7. Zhen WN, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR (2004) The national cancer data base report on squamous cell carcinoma of the base of tongue. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck 26:660–674

    Article  Google Scholar 

  8. Chera BS, Amdur RJ, Hinerman RW, Morris CG, Villaret DB, Werning JW, Mendenhall WM (2008) Definitive radiation therapy for squamous cell carcinoma of the soft palate. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck 30:1114–1119

    Article  Google Scholar 

  9. Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Calais G (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69–76

    Article  PubMed  Google Scholar 

  10. Pederson AW, Haraf DJ, Witt ME, Stenson KM, Vokes EE, Blair EA, Salama JK (2010) Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. Head Neck 32:1519–1527

    Article  PubMed  Google Scholar 

  11. Eisbruch A, Harris J, Garden AS, Chao CK, Straube W, Harari PM, Sanguineti G, Jones CU, Bosch WR, Ang KK (2010) Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 76:1333–1338

    Article  PubMed  Google Scholar 

  12. Liederbach E, Lewis CM, Yao K, Brockstein BE, Wang CH, Lutfi W, Bhayani MK (2015) A Contemporary Analysis of Surgical Trends in the Treatment of Squamous Cell Carcinoma of the Oropharynx from 1998 to 2012: A Report from the National Cancer Database. Ann Surg Oncol 22:4422–4431

    Article  PubMed  Google Scholar 

  13. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002, 40:IV-3-18

  14. Greene FL, American Joint Committee on Cancer., American Cancer Society.: AJCC cancer staging manual. 6th edn. New York: Springer-Verlag; 2002

  15. Bursac Z, Gauss CH, Williams DK, Hosmer DW (2008) Purposeful selection of variables in logistic regression. Source Code Biol Med 3:17

    Article  PubMed  PubMed Central  Google Scholar 

  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  CAS  PubMed  Google Scholar 

  17. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM, Har-El G, Lucente FE (1997) Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 107:1469–1475

    Article  CAS  PubMed  Google Scholar 

  18. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798–1804

    Article  CAS  PubMed  Google Scholar 

  19. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081–2086

    Article  CAS  PubMed  Google Scholar 

  20. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TPU, Iro H, Popella C, Schalhorn A (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16:1318–1324

    Article  CAS  PubMed  Google Scholar 

  21. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92–98

    Article  PubMed  Google Scholar 

  22. Forastiere AA, Trotti A (1999) Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. J Natl Cancer Inst 91:2065–2066

    Article  CAS  PubMed  Google Scholar 

  23. Goldenberg D, Mackley H, Koch W, Bann DV, Schaefer EW, Hollenbeak CS (2014) Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly. Oral Oncol 50:976–982

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chen AY, Schrag N, Hao YP, Stewart A, Ward E (2007) Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope 117:16–21

    Article  PubMed  Google Scholar 

  25. VanderWalde NA, Meyer AM, Liu H, Tyree SD, Zullig LL, Carpenter WR, Shores CD, Weissler MC, Hayes DN, Fleming M, Chera BS (2013) Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis. J Geriatr Oncol 4:262–270

    Article  PubMed  PubMed Central  Google Scholar 

  26. Borggreven PA, Kuik DJ, Langendijk JA, Doornaert P, de Bree R, Leemans CR (2005) Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction. Oral Oncol 41:358–364

    Article  PubMed  Google Scholar 

  27. de Cassia Braga Ribeiro K, Kowalski LP, Latorre MR (2003) Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 129:219–228

    Article  PubMed  Google Scholar 

  28. Steiner W, Fierek O, Ambrosch P, Hommerich CP, Kron M (2003) Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 129:36–43

    Article  PubMed  Google Scholar 

  29. Zenga J, Wilson M, Adkins DR, Gay HA, Haughey BH, Kallogjeri D, Michel LS, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B (2015) Treatment outcomes for T4 Oropharyngeal squamous cell carcinoma. Jama Otolaryngol Head and Neck Surg 141:1118–1127

    Article  Google Scholar 

  30. Zevallos JP, Mitra N, Swisher-McClure S (2016) Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma. Head Neck 38:402–409

    Article  PubMed  Google Scholar 

  31. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956

    Article  PubMed  Google Scholar 

  32. Polednak AP, Phillips C (2014) Surveillance of the frequency and results of testing of incident oropharyngeal cancers for human papillomavirus: the potential role of population-based cancer registries. J Regist Manag 41:113–119

    Google Scholar 

Download references

Acknowledgments

Bobbi J. Matt, RHIT-CTR and Donna M. Gress, RHIT-CTR, for assistance with data analysis.

Funding

This work was supported in part under NIH/NCI contract number HHSN261201300020I/HHSN26100006 with University of Iowa (MEC, JAS, CC). This work was also supported by the University of Iowa Holden Comprehensive Cancer Center, which is funded in part by NIH/NCI P30 CA086862.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nitin A. Pagedar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pagedar, N.A., Chioreso, C., Schlichting, J.A. et al. Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis. Cancer Causes Control 28, 1085–1093 (2017). https://doi.org/10.1007/s10552-017-0938-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-017-0938-3

Keywords

Navigation